论文部分内容阅读
银杏类药物是植物药开发的热点之一。银杏叶中的有效成份对心脑血管疾病具有独特的药理作用,被广泛用作治疗和预防心脑血管疾病药物。我国的银杏资源占世界总量的70％,主要来源为人工栽培银杏叶。目前国内银杏叶经济利用方式主要有:出口银杏叶或银杏叶标准提取物EGb_(761)属廉价出卖资源。急需进行银杏叶的深加工,生产高附加值的新药产品。
Ginkgo drugs are one of the hot spots in the development of botanical drugs. The active ingredients in Ginkgo biloba leaves have unique pharmacological effects on cardiovascular and cerebrovascular diseases and are widely used as drugs for the treatment and prevention of cardiovascular and cerebrovascular diseases. China’s ginkgo resources account for 70% of the world’s total, and its main source is the artificial cultivation of Ginkgo biloba leaves. At present, the main economic utilization methods of Ginkgo biloba leaves are: export Ginkgo biloba leaf or Ginkgo biloba standard extract EGb_(761) is a cheap sale of resources. The deep processing of Ginkgo biloba leaves is urgently needed to produce high value-added new drug products.